Want to join the conversation?
$WAT 2Q15 Q&A: Willoughby of Cleveland had a question regarding pharma demand. Douglas replied that growth is not coming from classical big pharma accounts, which were low single-digits to flat. Most of growth was coming from specialty pharma, generics, big and small biotech accounts, most of which were new volume-based initiatives.
Any idea why some investors are happy about the disastrous $UA results??
Wow! GM killed it with earnings today! Did not expect this after $F gave the feeling it will eclipse the Chevy maker completely!
Oil rebound starting to show up in energy stocks. $XOM $CVX
I have a feeling "CLOUDy" days are ahead, with $AMZN leading the pack.
$AAL is giving pay hikes to its employees but investors are sulking.